Forte Biosciences

Focus: Forte Biosciences is a Dallas-based biotechnology company focused on immunology and dermatology, particularly atopic dermatitis treatment. Company scale and founding details are not publicly available in provided data.

Immunology Dermatology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Forte Biosciences

AI assessmentNot Hiring

No open roles listed right now. Follow Forte Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

45 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Midstream urine collection device

Lower Urinary Tract Symptoms

N/A

Clinical Trials (1)

NCT03729336PEEZY Midstream Urine Device Compared to Catheterized Urine Sample

N/A

Help build intelligence for Forte Biosciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline in high-value immunology/dermatology space with FB102 in Phase 2 for celiac disease and FB-401 in Phase 2 for atopic dermatitis
Received private funding as of August 2023, indicating investor confidence in the platform
Specialized focus on atopic dermatitis positions the company in a large, underserved market with significant commercial potential

Watch Out For

Zero active job openings indicate company is not in active hiring mode, limiting near-term career entry points
Pre-revenue biotech status with limited financial visibility creates uncertainty around long-term stability and compensation competitiveness

Generated by Claude from Forte Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

A Longitudinal Study of Severe and Enduring Eating Disorders

Eating Disorders

N/A

Clinical Trials (1)

NCT06752304A Longitudinal Study of Severe and Enduring Eating Disorders

N/A

Assist Reablement

Reablement

N/A

Clinical Trials (1)

NCT06749080ASSIST 2.0: a Reablement Program for Healthy Ageing

N/A

Sealed therapeutic shoe

Diabetic Foot

N/A

Clinical Trials (1)

NCT04085926Sealed Therapeutic Shoe as Treatment of Diabetic Foot Ulcers

N/A

Quality Improvement Collaborative

Contraception

N/A

Clinical Trials (1)

NCT05521646Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative

N/A

Web-based self-report questionnaires

Mental Health Issue

N/A

Clinical Trials (1)

NCT04465435Sustainable UNiversity Life (SUN) Study

N/A

Registry review

Identification of Family Violence

N/A

Clinical Trials (1)

NCT07158983Evaluation of a Child Health Care Program for Early Identification of Family Violence

N/A

a usual follow-up with Rehabkompassen®

Stroke

N/A

Clinical Trials (1)

NCT04915027Rehabkompassen® - a Patient-centered Digital Follow-up Tool in the Post-stroke Continuum of Care

N/A

Acceptance and Commitment Therapy

Chronic Pain

N/A

Clinical Trials (1)

NCT06981312Internet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education.

N/A

Make My Day - stroke prevention program

Stroke

N/A

Clinical Trials (1)

NCT05279508Make My Day - a Stroke Prevention Program

N/A

interdisciplinary treatment

Chronic Pain

N/A

Clinical Trials (1)

NCT04598373Effects of Interdisciplinary Treatment on Sickness Absence in Patients With Chronic Pain

N/A

Alcohol biomarker Phosphatidylethanol

Hypertension

N/A

Clinical Trials (1)

NCT05580549Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primary Care

N/A

Person-centred care transition support

Stroke

N/A

Clinical Trials (1)

NCT05646589A Person-centred Care Transition Support for People With Stroke/TIA

N/A

Internet-based dietetic treatment with video calls

Overweight and Obesity

N/A

Clinical Trials (1)

NCT04245384Dietitian Online - Internet-based Dietetic Treatment Within Health Care Services

N/A

Interdisciplinary treatment

Pain, Chronic

N/A

Clinical Trials (1)

NCT07081737Person-Centred AI Support in Interdisciplinary Rehabilitation for Chronic Pain

N/A

MINISTOP 2.0

Obesity, Childhood

N/A

Clinical Trials (1)

NCT04147039A Mobile Phone App to Promote Healthy Diet and Physical Activity in 2.5-year-olds

N/A

fall prevention program

Multiple Sclerosis

N/A

Clinical Trials (1)

NCT04317716A Self-management Program to Prevent Falls in People With Multiple Sclerosis

N/A

Endometriosis surgery

Endometriosis

N/A

Clinical Trials (1)

NCT07240363First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis

N/A

Mobile phone supported and team based rehabilitation

Stroke

N/A

Clinical Trials (1)

NCT04351178F@ce 2.0 - Information and Communication Technology-based Rehabilitation Intervention After Stroke in Sweden

N/A

Blended Trauma-Focused Cognitive Behavioral Therapy with Compassion

Post-traumatic Stress Disorder (PTSD)

N/A

Clinical Trials (1)

NCT07407946Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion

N/A

Voice recording

Concussion

N/A

Clinical Trials (1)

NCT02069795Speech Analysis as a Diagnostic Tool for Mild Traumatic Brain Injury

N/A

Safety Planning Intervention

Suicide Attempt

N/A

Clinical Trials (1)

NCT07469917Safety Planning Intervention in Swedish Healthcare: A Multisite Study for Suicide Prevention

N/A

Foot Exam Follow-Up

Ankle Impingement

N/A

Clinical Trials (1)

NCT04467099Prevalence of Flexor Hallucis Longus Tears, Associated Os Trigonum Excision, and Return to Play

N/A

Health4Life app

Healthy

N/A

Clinical Trials (1)

NCT06798597Health4Life a Digital Intervention to Promote Healthy Lifestyle Behaviours From the Start of Life

N/A

AFFEKT - a manual based brief parent program for parents of children

Behavior, Child

N/A

Clinical Trials (1)

NCT05983705The Effect and Experience of the Parental Program AFFEKT

N/A

Safe Step

Accidental Falls

N/A

Clinical Trials (1)

NCT02916849A Feasibility Study of a Mobile Application Intervention to Promote Strength and Balance Exercises in Older People

N/A

Family Talk Intervention

Terminal Illness

N/A

Clinical Trials (1)

NCT05365919Family Talk Intervention in the Context of Specialised Palliative Home Care

N/A

Culture

Infection

N/A

Clinical Trials (1)

NCT02602548The Incidence and Incubation Period of False Positive Cultures in Shoulder Surgery

N/A

Unfolding Severe and Enduring Eating Disorders (U-SEED)

Eating Disorders

N/A

Clinical Trials (1)

NCT06592963Unfolding Severe and Enduring Eating Disorders (U-SEED)

N/A

Psychological treatment for persistent fatigue

Fatigue

N/A

Clinical Trials (1)

NCT06341751Psychological Treatment for Persistent Fatigue

N/A

I-Navigator ACT

Parents

N/A

Clinical Trials (1)

NCT05940168Internet-delivered ACT (I-Navigator ACT) for Parents of Children With Disabilities

N/A

Social prescribing in Sweden

Loneliness

N/A

Clinical Trials (1)

NCT04336553Social Prescribing in Sweden (SPiS)

N/A

Intervention group Case Manager

Frailty

N/A

Clinical Trials (1)

NCT06368674Bridging the Gap: Creating a Continuum of Care

N/A

Milk

Oxidative Stress

N/A

Clinical Trials (1)

NCT03821116Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammation

N/A

Container

Urinary Tract Infections

N/A

Clinical Trials (1)

NCT03131609Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department

N/A

Radically Open Dialectical Behavior Therapy

Eating Disorders

N/A

Clinical Trials (1)

NCT06792071Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders

N/A

Motivational Interviewing

Medication Adherence

N/A

Clinical Trials (1)

NCT02823795The Supporting Patient Activation in Transition to Home Intervention

N/A

Child Centred Health Dialog

Child, Only

N/A

Clinical Trials (1)

NCT04260672Child-Centred Health Dialogue in Child Health Services

N/A

No intervention

Chronic Diseases in Children

N/A

Clinical Trials (1)

NCT05809479NICE - Nutritional Impact on Immunological Maturation During Childhood in Relation to the Environment

N/A

Signature Cord Prime

Osteoarthritis, Knee

Phase 1

Clinical Trials (1)

NCT05234489Study to Assess Signature Cord Product in Patients With Symptomatic OA of the Knee

Phase 1

FB102

Vitiligo

Phase 1

Clinical Trials (1)

NCT06905873A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo

Phase 1

FB102

Alopecia Areata

Phase 1

Clinical Trials (1)

NCT07205159A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

Phase 1

FB-401

Atopic Dermatitis

Phase 2

Clinical Trials (1)

NCT04504279Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Phase 2

FB-401

Atopic Dermatitis

Phase 2

Clinical Trials (1)

NCT04936113Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

Phase 2

FB102

Celiac Disease

Phase 2

Clinical Trials (1)

NCT06982963Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease

Phase 2